AbbVie Inc. is 466.9x more valuable than Olema Pharmaceuticals, Inc. by market capitalization ($399.47 B vs $855.57 M). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | OLMA | ABBV |
|---|---|---|
| Market cap | $855.57 M | $399.47 B |
| US-listed rank | #2661 | #28 |
| Revenue (latest FY) | - | $61.16B |
| Net income (latest FY) | -$162.45M | $4.23B |
| Net margin | - | 6.9% |
| P/E (trailing FY) | - | 94.5 |
| SEC filings | 538 | 1,008 |
AbbVie Inc. is 466.9x more valuable than Olema Pharmaceuticals, Inc. by market capitalization ($399.47 B vs $855.57 M).
Full pages: Olema Pharmaceuticals, Inc. and AbbVie Inc., or browse the full rankings.